RITUXIMAB

210159 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB:

# Side effect Count
0 OFF LABEL USE 40662
1 DRUG INEFFECTIVE 34033
2 RHEUMATOID ARTHRITIS 20084
3 PAIN 17704
4 FATIGUE 17225
5 RASH 13455
6 ARTHRALGIA 13300
7 PNEUMONIA 12911
8 INFUSION RELATED REACTION 12680
9 DRUG INTOLERANCE 12498
See all common reactions for RITUXIMAB

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5755 0.8204
1 PEMPHIGUS 9375 0.7639
2 RED BLOOD CELL SEDIMENTATION RATE 211 0.7590
3 SWOLLEN JOINT COUNT INCREASED 2326 0.7554
4 RHEUMATIC FEVER 3199 0.7419
5 VACCINE INTERACTION 227 0.7418
6 RHEUMATOID FACTOR POSITIVE 4177 0.7336
7 SWOLLEN JOINT COUNT 176 0.7243
8 C-REACTIVE PROTEIN 640 0.7143
9 LUPUS VULGARIS 827 0.7038
See all enriched reactions for RITUXIMAB